CDCA7L anticorps (Middle Region)
-
- Antigène Voir toutes CDCA7L Anticorps
- CDCA7L (Cell Division Cycle Associated 7-Like (CDCA7L))
-
Épitope
- Middle Region
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDCA7L est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- CDCA7 L antibody was raised against the middle region of CDCA7
- Purification
- Affinity purified
- Immunogène
- CDCA7 L antibody was raised using the middle region of CDCA7 corresponding to a region with amino acids PPCRGICNCSYCRKRDGRCATGILIHLAKFYGYDNVKEYLESLQKELVED
- Top Product
- Discover our top product CDCA7L Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
CDCA7L Blocking Peptide, catalog no. 33R-7245, is also available for use as a blocking control in assays to test for specificity of this CDCA7L antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CDCA0 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- CDCA7L (Cell Division Cycle Associated 7-Like (CDCA7L))
- Autre désignation
- CDCA7L (CDCA7L Produits)
- Synonymes
- anticorps ram2, anticorps MGC154777, anticorps BC006933, anticorps JPO2, anticorps R1, anticorps RAM2, anticorps RAPGEF5, anticorps cell division cycle associated 7 like, anticorps cell division cycle associated 7 like L homeolog, anticorps cell division cycle-associated 7-like protein, anticorps CDCA7L, anticorps cdca7l.L, anticorps LOC100454683, anticorps Cdca7l
- Sujet
- CDCA7L plays an important oncogenic role in mediating the full transforming effect of MYC in medulloblastoma cells. CDCA7L is involved in apoptotic signaling pathways. CDCA7L may act downstream of P38-kinase and BCL-2, but upstream of CASP3/caspase-3 as well as CCND1/cyclin D1 and E2F1.
- Poids moléculaire
- 46 kDa (MW of target protein)
-